Cargando…

Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study

OBJECTIVE: To characterise the optimal targeting of age and risk groups for COVID-19 vaccines. DESIGN: Motivated by policies in Japan and elsewhere, we consider rollouts that target a mix of age and risk groups when distributing the vaccines. We identify the optimal group mix for three policy object...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongming, Ibuka, Yoko, Nakamura, Ryota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748520/
https://www.ncbi.nlm.nih.gov/pubmed/36523241
http://dx.doi.org/10.1136/bmjopen-2022-061139
_version_ 1784849843746766848
author Wang, Hongming
Ibuka, Yoko
Nakamura, Ryota
author_facet Wang, Hongming
Ibuka, Yoko
Nakamura, Ryota
author_sort Wang, Hongming
collection PubMed
description OBJECTIVE: To characterise the optimal targeting of age and risk groups for COVID-19 vaccines. DESIGN: Motivated by policies in Japan and elsewhere, we consider rollouts that target a mix of age and risk groups when distributing the vaccines. We identify the optimal group mix for three policy objectives: reducing deaths, reducing cases and reducing severe cases. SETTING: Japan, a country where the rollout occurred over multiple stages targeting a mix of age and risk groups in each stage. PRIMARY OUTCOMES: We use official statistics on COVID-19 deaths to quantify the virus transmission patterns in Japan. We then search over all possible group mix across rollout stages to identify the optimal strategies under different policy objectives and virus and vaccination conditions. RESULTS: Low-risk young adults can be targeted together with the high-risk population and the elderly to optimally reduce deaths, cases and severe cases under high virus transmissibility. Compared with targeting the elderly or the high-risk population only, applying optimal group mix can further reduce deaths and severe cases by over 60%. High-efficacy vaccines can mitigate the health loss under suboptimal targeting in the rollout. CONCLUSIONS: Mixing age and risk groups outperforms targeting individual groups separately, and optimising the group mix can substantially increase the health benefits of vaccines. Additional policy measures boosting vaccine efficacy are necessary under outbreaks of transmissible variants.
format Online
Article
Text
id pubmed-9748520
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-97485202022-12-14 Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study Wang, Hongming Ibuka, Yoko Nakamura, Ryota BMJ Open Health Policy OBJECTIVE: To characterise the optimal targeting of age and risk groups for COVID-19 vaccines. DESIGN: Motivated by policies in Japan and elsewhere, we consider rollouts that target a mix of age and risk groups when distributing the vaccines. We identify the optimal group mix for three policy objectives: reducing deaths, reducing cases and reducing severe cases. SETTING: Japan, a country where the rollout occurred over multiple stages targeting a mix of age and risk groups in each stage. PRIMARY OUTCOMES: We use official statistics on COVID-19 deaths to quantify the virus transmission patterns in Japan. We then search over all possible group mix across rollout stages to identify the optimal strategies under different policy objectives and virus and vaccination conditions. RESULTS: Low-risk young adults can be targeted together with the high-risk population and the elderly to optimally reduce deaths, cases and severe cases under high virus transmissibility. Compared with targeting the elderly or the high-risk population only, applying optimal group mix can further reduce deaths and severe cases by over 60%. High-efficacy vaccines can mitigate the health loss under suboptimal targeting in the rollout. CONCLUSIONS: Mixing age and risk groups outperforms targeting individual groups separately, and optimising the group mix can substantially increase the health benefits of vaccines. Additional policy measures boosting vaccine efficacy are necessary under outbreaks of transmissible variants. BMJ Publishing Group 2022-12-12 /pmc/articles/PMC9748520/ /pubmed/36523241 http://dx.doi.org/10.1136/bmjopen-2022-061139 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Health Policy
Wang, Hongming
Ibuka, Yoko
Nakamura, Ryota
Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study
title Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study
title_full Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study
title_fullStr Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study
title_full_unstemmed Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study
title_short Mixing age and risk groups for accessing COVID-19 vaccines: a modelling study
title_sort mixing age and risk groups for accessing covid-19 vaccines: a modelling study
topic Health Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748520/
https://www.ncbi.nlm.nih.gov/pubmed/36523241
http://dx.doi.org/10.1136/bmjopen-2022-061139
work_keys_str_mv AT wanghongming mixingageandriskgroupsforaccessingcovid19vaccinesamodellingstudy
AT ibukayoko mixingageandriskgroupsforaccessingcovid19vaccinesamodellingstudy
AT nakamuraryota mixingageandriskgroupsforaccessingcovid19vaccinesamodellingstudy